Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

Overview of attention for article published in Arthritis Research & Therapy, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 51 Mendeley

Summary Blogs X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

John J. Cush, MD, 21 Dec 2016

20 yrs ago Rx w/ Campath-1(alemtuzumab)caused cytopenia